WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $8.4360, but opened at $9.12. WuXi Biologics (Cayman) shares last traded at $9.12, with a volume of 112 shares traded.
WuXi Biologics (Cayman) Stock Performance
The business has a 50-day moving average of $8.68 and a two-hundred day moving average of $8.96.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Recommended Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
- 3 Defense Giants Boosting Dividends as Shares Take a Ride
- Powerhouse Williams-Sonoma Heading to Fresh Highs in 2026
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
